HIPRA Trademark

Trademark Overview

On Wednesday, October 16, 2013, a trademark application was filed for HIPRA with the United States Patent and Trademark Office. The USPTO has given the HIPRA trademark a serial number of 79140069. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, October 16, 2023. This trademark is owned by LABORATORIOS HIPRA, S.A.. The HIPRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary products, namely, diagnostic kits consisting primarily of monoclonal or polyclonal antibodies, buffers and reagents for use in disease testing; vaccines; injectable pharmaceuticals for treatment of bacterial infections and for the treatment of vitamin and mineral deficiencies; anti-inflammatory injectable pharmaceuticals; oral pharmaceutical solutions for treatment of bacterial infections; intramammary ointments for the treatment of bacterial infections; oral pharmaceuticals in powder form for the treatment of bacterial infections; hormones [ ; sanitary preparations for medical use; food for babies; nutritional supplements for humans and animals; medical plasters; medical and surgical dressings; teeth filling and dental impression materials; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides ]
hipra

General Information

Serial Number79140069
Word MarkHIPRA
Filing DateWednesday, October 16, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, October 16, 2023
Registration Number4705723
Registration DateTuesday, March 24, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 6, 2015

Trademark Statements

Description of MarkThe mark consists of the white letters "HIPRA", a white horse's head with a white and blue mane, and the white outline of a beaker, all contained within a blue rectangle.
Goods and ServicesPharmaceutical and veterinary products, namely, diagnostic kits consisting primarily of monoclonal or polyclonal antibodies, buffers and reagents for use in disease testing; vaccines; injectable pharmaceuticals for treatment of bacterial infections and for the treatment of vitamin and mineral deficiencies; anti-inflammatory injectable pharmaceuticals; oral pharmaceutical solutions for treatment of bacterial infections; intramammary ointments for the treatment of bacterial infections; oral pharmaceuticals in powder form for the treatment of bacterial infections; hormones [ ; sanitary preparations for medical use; food for babies; nutritional supplements for humans and animals; medical plasters; medical and surgical dressings; teeth filling and dental impression materials; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides ]
Indication of Colors claimedThe color(s) blue and white is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, October 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATORIOS HIPRA, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAMER (Girona) E-17170
ES
Party NameLABORATORIOS HIPRA, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameLABORATORIOS HIPRA, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Thursday, December 19, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 27, 2013APPLICATION FILING RECEIPT MAILED
Saturday, February 1, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 4, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 22, 2014REFUSAL PROCESSED BY IB
Tuesday, July 29, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 31, 2014ASSIGNED TO EXAMINER
Friday, January 31, 2014NON-FINAL ACTION WRITTEN
Tuesday, February 4, 2014REFUSAL PROCESSED BY MPU
Tuesday, July 29, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 17, 2014EXAMINER'S AMENDMENT ENTERED
Friday, August 1, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 1, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 1, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 20, 2014FINAL REFUSAL WRITTEN
Wednesday, August 20, 2014FINAL REFUSAL E-MAILED
Wednesday, August 20, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 17, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, November 17, 2014EXAMINERS AMENDMENT E-MAILED
Monday, November 17, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, January 3, 2015NOTIFICATION PROCESSED BY IB
Tuesday, March 24, 2015REGISTERED-PRINCIPAL REGISTER
Monday, November 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 4, 2014ASSIGNED TO LIE
Thursday, December 4, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 17, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 17, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 6, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 24, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, August 3, 2015FINAL DISPOSITION PROCESSED
Monday, August 3, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 21, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 24, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, March 23, 2021TEAS SECTION 71 RECEIVED
Wednesday, June 30, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, June 30, 2021REGISTERED-SEC.71 ACCEPTED
Saturday, November 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 6, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, May 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, May 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 24, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, March 2, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, June 29, 2022INVALIDATION PROCESSED
Thursday, June 30, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, August 8, 2022PARTIAL INVALIDATION PROCESSED BY THE IB

Related Keywords

hipra treatment bacterial infections medical pharmaceuticals injectable pharmaceutical oral preparations humans